Form 4: Ptc Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Pierre Gravier, CHIEF FINANCIAL OFFICER of Ptc Therapeutics, Inc., sold 3,494 shares of common stock on July 14, 2026 for $80.35 per share.
Summary
- Open-market sale: disposed of 3,494 Common Stock at $80.35 ($280,743) on July 14, 2026; holds 83,986 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $280,743 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Pierre Gravier — Officer (CHIEF FINANCIAL OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market sale | Common Stock | 3,494 | $80 | $280.7K | 83,986 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market sale (3,494 shares) |
Keywords
insider transaction, Form 4, PTCT, PTC THERAPEUTICS, INC., bearish, Pierre Gravier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.